Metadata
| Source Table | grants |
| Source ID | fRshipNxaC |
| Description | to University of Southern California, USD 160000, 2023-10 |
| Source URL | coefficientgiving.org/funds/ |
| Parent | Coefficient Giving |
| Children | — |
| Created | Mar 12, 2026, 5:54 AM |
| Updated | Mar 25, 2026, 3:13 AM |
| Synced | Mar 19, 2026, 8:57 PM |
Record Data
id | fRshipNxaC |
organizationId | Coefficient Giving(organization) |
granteeId | University of Southern California(organization) |
orgEntityId | Coefficient Giving(organization) |
orgDisplayName | — |
granteeEntityId | University of Southern California(organization) |
granteeDisplayName | usc |
name | University of Southern California — Linezolid Trial for Syphilis |
amount | 160000 |
currency | USD |
period | — |
date | 2023-10 |
status | — |
source | coefficientgiving.org/funds/ |
notes | [Human Health and Wellbeing] Open Philanthropy recommended a grant of $160,000 over two years to the University of Southern California to support a clinical trial led by Dr. Jeffrey Klausner testing linezolid as a treatment for syphilis. Linezolid is an inexpensive antibiotic commonly used to treat … |
programId | ONN00wZd8U |
dataSourceId | — |
Source Check Verdicts
confirmed95% confidence
Last checked: 4/29/2026
1 → confirmed
Debug info
Thing ID: fRshipNxaC
Source Table: grants
Source ID: fRshipNxaC
Parent Thing ID: sid_ULjDXpSLCI